skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles

Authors:
; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1394716
Resource Type:
Journal Article: Published Article
Journal Name:
Cell Chemical Biology
Additional Journal Information:
Journal Volume: 23; Journal Issue: 9; Related Information: CHORUS Timestamp: 2017-09-25 16:45:54; Journal ID: ISSN 2451-9456
Publisher:
Elsevier
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Aleem, Saadat U., Georghiou, George, Kleiner, Ralph E., Guja, Kip E., Craddock, Barbara P., Lyczek, Agatha, Chan, Alix I., Garcia-Diaz, Miguel, Miller, W. Todd, Liu, David R., and Seeliger, Markus A. Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles. Country unknown/Code not available: N. p., 2016. Web. doi:10.1016/j.chembiol.2016.07.017.
Aleem, Saadat U., Georghiou, George, Kleiner, Ralph E., Guja, Kip E., Craddock, Barbara P., Lyczek, Agatha, Chan, Alix I., Garcia-Diaz, Miguel, Miller, W. Todd, Liu, David R., & Seeliger, Markus A. Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles. Country unknown/Code not available. doi:10.1016/j.chembiol.2016.07.017.
Aleem, Saadat U., Georghiou, George, Kleiner, Ralph E., Guja, Kip E., Craddock, Barbara P., Lyczek, Agatha, Chan, Alix I., Garcia-Diaz, Miguel, Miller, W. Todd, Liu, David R., and Seeliger, Markus A. 2016. "Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles". Country unknown/Code not available. doi:10.1016/j.chembiol.2016.07.017.
@article{osti_1394716,
title = {Structural and Biochemical Basis for Intracellular Kinase Inhibition by Src-specific Peptidic Macrocycles},
author = {Aleem, Saadat U. and Georghiou, George and Kleiner, Ralph E. and Guja, Kip E. and Craddock, Barbara P. and Lyczek, Agatha and Chan, Alix I. and Garcia-Diaz, Miguel and Miller, W. Todd and Liu, David R. and Seeliger, Markus A.},
abstractNote = {},
doi = {10.1016/j.chembiol.2016.07.017},
journal = {Cell Chemical Biology},
number = 9,
volume = 23,
place = {Country unknown/Code not available},
year = 2016,
month = 9
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at 10.1016/j.chembiol.2016.07.017

Save / Share:
  • Hymeglusin (1233A, F244, L-659-699) is established as a specific {beta}-lactone inhibitor of eukaryotic hydroxymethylglutaryl-CoA synthase (HMGCS). Inhibition results from formation of a thioester adduct to the active site cysteine. In contrast, the effects of hymeglusin on bacterial HMG-CoA synthase, mvaS, have been minimally characterized. Hymeglusin blocks growth of Enterococcus faecalis. After removal of the inhibitor from culture media, a growth curve inflection point at 3.1 h is observed (vs 0.7 h for the uninhibited control). Upon hymeglusin inactivation of purified E. faecalis mvaS, the thioester adduct is more stable than that measured for human HMGCS. Hydroxylamine cleaves the thioester adduct;more » substantial enzyme activity is restored at a rate that is 8-fold faster for human HMGCS than for mvaS. Structural results explain these differences in enzyme-inhibitor thioester adduct stability and solvent accessibility. The E. faecalis mvaS-hymeglusin cocrystal structure (1.95 {angstrom}) reveals virtually complete occlusion of the bound inhibitor in a narrow tunnel that is largely sequestered from bulk solvent. In contrast, eukaryotic (Brassica juncea) HMGCS binds hymeglusin in a more solvent-exposed cavity.« less
  • The receptor tyrosine kinase c-Met is implicated in oncogenesis and is the target for several small molecule and biologic agents in clinical trials for the treatment of cancer. Binding of the hepatocyte growth factor to the cell surface receptor of c-Met induces activation via autophosphorylation of the kinase domain. Here we describe the structural basis of c-Met activation upon autophosphorylation and the selective small molecule inhibiton of autophosphorylated c-Met. MK-2461 is a potent c-Met inhibitor that is selective for the phosphorylated state of the enzyme. Compound 1 is an MK-2461 analog with a 20-fold enthalpy-driven preference for the autophosphorylated overmore » unphosphorylated c-Met kinase domain. The crystal structure of the unbound kinase domain phosphorylated at Tyr-1234 and Tyr-1235 shows that activation loop phosphorylation leads to the ejection and disorder of the activation loop and rearrangement of helix {alpha}C and the G loop to generate a viable active site. Helix {alpha}C adopts a orientation different from that seen in activation loop mutants. The crystal structure of the complex formed by the autophosphorylated c-Met kinase domain and compound 1 reveals a significant induced fit conformational change of the G loop and ordering of the activation loop, explaining the selectivity of compound 1 for the autophosphorylated state. The results highlight the role of structural plasticity within the kinase domain in imparting the specificity of ligand binding and provide the framework for structure-guided design of activated c-Met inhibitors.« less
  • Casein kinase 1 epsilon (CK1ε) and its closest homologue CK1δ are key regulators of diverse cellular processes. We report two crystal structures of PF4800567, a potent and selective inhibitor of CK1ε, bound to the kinase domains of human CK1ε and CK1δ as well as one apo CK1ε crystal structure. These structures provide a molecular basis for the strong and specific inhibitor interactions with CK1ε and suggest clues for further development of CK1δ inhibitors.